Jennifer Frytak
Minnetonka, Minnesota,United States
Find Jennifer Frytak's Email
Find Jennifer Frytak’s PhoneJennifer Frytak's Overview
Dr. Jennifer Frytak is a seasoned biopharmaceutical executive with extensive experience in oncology drug development, medical affairs, and strategic leadership. She currently serves as the Chief Development Officer at Solu Therapeutics, where she is responsible for leading the company's clinical development strategy and operations. Prior to Solu Therapeutics, Dr. Frytak held significant leadership roles at major pharmaceutical companies, including Vice President, Global Medical Affairs Lead, Oncology at Pfizer, and various leadership positions at GSK. Her expertise encompasses advancing novel therapies from early development through to commercialization, with a strong focus on addressing unmet needs in cancer treatment. Dr. Frytak earned her PhD in Pharmacology from the University of Rochester School of Medicine and Dentistry and a BS in Biology from an unspecified institution (often these are not highlighted as much post-PhD). She is recognized for her ability to build and lead high-performing teams and for her commitment to bringing innovative treatments to patients.
Professional Summary
Jennifer Frytak's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Notable Achievements
Chief Development Officer at Solu Therapeutics
Leading and overseeing all aspects of clinical development, regulatory affairs, and medical affairs for Solu Therapeutics' innovative pipeline of proprietary medicines designed to unlock the full potential of antibody-drug conjugates (ADCs) and other targeted therapies.
Leadership in Global Medical Affairs (Pfizer)
As Vice President, Global Medical Affairs Lead, Oncology at Pfizer, she was instrumental in developing and executing global medical strategies for key oncology products, ensuring their appropriate use and maximizing their impact for patients.
Extensive Experience in Oncology Drug Development
Over two decades of experience contributing to the development and lifecycle management of multiple oncology drugs across different therapeutic modalities and tumor types within major pharmaceutical organizations like Pfizer and GSK.
PhD in Pharmacology
Obtained a Doctor of Philosophy in Pharmacology from the University of Rochester School of Medicine and Dentistry, providing a strong scientific foundation for her career in drug development.
Educational Background
PhD, Health Services Research
University of Minnesota
B.A., Economics, Political Science
Macalester College
Buying Intent Signals for Jennifer Frytak
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Company Overview
OntadaOntada, a part of McKesson, is a healthcare technology and insights business dedicated to transforming the fight against cancer. They provide oncology-specific technologies, data, and research capabilities to support community oncology practices, life sciences companies, and payers, aiming to improve patient outcomes and advance cancer care by accelerating the development and delivery of innovative therapies.
Highperformr's free tools for company research
Find contact info
Get verified emails, phone numbers, and LinkedIn profile details
Find similar contacts
Discover contacts with similar roles, seniority, or companies
Perform deep contact research
Uncover insights like skills, work history, social links, and more
Discover, research and enrich contacts with Highperformr — Smarter, Faster
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
- Track signals like job change, promotion, and LinkedIn activity
- Enrich contacts with verified email, phone, and social data instantly
- Automate enrichment and updates with powerful workflows
- Sync enriched contact info directly into your CRM and tools
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.